Javascript must be enabled to continue!
Rate of Homologous Desensitization and Internalization of the GLP-1 Receptor
View through CrossRef
The glucagon-like peptide-1 receptor (GLP-1R) is an important target in the treatment of type 2 diabetes mellitus. The aim of this study was to compare the rate of agonist stimulated desensitization and internalization of GLP-1R. To this end, an N-terminally myc-tagged GLP-1R was stably expressed in HEK-293 cells. Homologous desensitization was assessed by measuring the cAMP response to agonist stimulation following pre-incubation with agonist for up to 120 min. Receptor internalization was monitored using an indirect ELISA-based method and confocal microscopy. Pre-incubation with GLP-1 resulted in a time-dependent loss of response to a second stimulation. Washing cells following pre-incubation failed to bring cAMP levels back to basal. Taking this into account, two desensitization rates were calculated: “apparent” (t1/2 = 19.27 min) and “net” (t1/2 = 2.99 min). Incubation of cells with GLP-1 also resulted in a time-dependent loss of receptor cell surface expression (t1/2 = 2.05 min). Rapid agonist-stimulated internalization of GLP-1R was confirmed using confocal microscopy. Stimulation of GLP-1R with GLP-1 results in rapid desensitization and internalization of the receptor. Interestingly, the rate of “net” desensitization closely matches the rate of internalization. Our results suggest that agonist-bound GLP-1R continues to generate cAMP after it has been internalized.
Title: Rate of Homologous Desensitization and Internalization of the GLP-1 Receptor
Description:
The glucagon-like peptide-1 receptor (GLP-1R) is an important target in the treatment of type 2 diabetes mellitus.
The aim of this study was to compare the rate of agonist stimulated desensitization and internalization of GLP-1R.
To this end, an N-terminally myc-tagged GLP-1R was stably expressed in HEK-293 cells.
Homologous desensitization was assessed by measuring the cAMP response to agonist stimulation following pre-incubation with agonist for up to 120 min.
Receptor internalization was monitored using an indirect ELISA-based method and confocal microscopy.
Pre-incubation with GLP-1 resulted in a time-dependent loss of response to a second stimulation.
Washing cells following pre-incubation failed to bring cAMP levels back to basal.
Taking this into account, two desensitization rates were calculated: “apparent” (t1/2 = 19.
27 min) and “net” (t1/2 = 2.
99 min).
Incubation of cells with GLP-1 also resulted in a time-dependent loss of receptor cell surface expression (t1/2 = 2.
05 min).
Rapid agonist-stimulated internalization of GLP-1R was confirmed using confocal microscopy.
Stimulation of GLP-1R with GLP-1 results in rapid desensitization and internalization of the receptor.
Interestingly, the rate of “net” desensitization closely matches the rate of internalization.
Our results suggest that agonist-bound GLP-1R continues to generate cAMP after it has been internalized.
Related Results
Renal vasodilation induced by Glucagon‐like peptide‐1 is mediated only by the known receptor
Renal vasodilation induced by Glucagon‐like peptide‐1 is mediated only by the known receptor
Glucagon‐like peptide‐1 (GLP‐1) stimulates insulin release after a meal. The GLP‐1 receptor is found in many tissues including the renal vasculature. GLP‐1 increases renal blood fl...
THE POTENTIAL OF GLP-1 IN THE TREATMENT OF AUTOIMMUNE DISEASES: A REVIEW OF MECHANISMS AND CLINICAL DATA
THE POTENTIAL OF GLP-1 IN THE TREATMENT OF AUTOIMMUNE DISEASES: A REVIEW OF MECHANISMS AND CLINICAL DATA
Introduction: Autoimmune diseases are a heterogeneous group of disorders characterized by dysregulated immune responses against self-antigens, leading to chronic inflammation and p...
Intestinal and skin homeostasis : targeting inflammation and cancer
Intestinal and skin homeostasis : targeting inflammation and cancer
Homéostasie de l’intestin et de la peau : cibles et modèles pour étudier l’inflammation et la carcinogenèse
L’homéostasie des muqueuses intestinale et cutanée dépen...
Weight Loss-Independent Effect of Liraglutide on Insulin Sensitivity in Individuals with Obesity and Pre-Diabetes
Weight Loss-Independent Effect of Liraglutide on Insulin Sensitivity in Individuals with Obesity and Pre-Diabetes
<p dir="ltr">Metabolic effects of glucagon-like peptide-1 (GLP-1) receptor agonists are confounded by weight loss and not fully recapitulated by increasing endogenous GLP-1. ...
Glucagon‐like peptide‐1 receptor agonists and upper endoscopy: a real‐world experience
Glucagon‐like peptide‐1 receptor agonists and upper endoscopy: a real‐world experience
AbstractObjectiveIncreased use of glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) has raised safety concerns during endoscopy due to their mechanism of delaying gastric emptyi...
Abstract 95: Glucagon Like Peptide-1 (GLP-1) Does Not Cause Vasodilation Even When Dipeptidyl Peptidase 4 (DPP4) is Inhibited
Abstract 95: Glucagon Like Peptide-1 (GLP-1) Does Not Cause Vasodilation Even When Dipeptidyl Peptidase 4 (DPP4) is Inhibited
Glucagon-like peptide 1 (GLP-1) causes direct vasodilation in animal models. Dipeptidyl peptidase 4 (DPP4) inhibitors improve glycemic control in diabetic patients by preventing th...
The role of protein kinase C in the desensitization of rat pancreatic islets to cholinergic stimulation
The role of protein kinase C in the desensitization of rat pancreatic islets to cholinergic stimulation
It is well known that protein kinase C (PKC) plays an important role in mediating insulin secretion in response to cholinergic stimulation. In various cells PKC also mediates a des...
Abstract WP109: Glucagon-Like Peptide-1 Has Anti-Inflammatory Effects Through Increasing IB1, A Scaffold Regulator Of JNK, In Cerebral Ischemia
Abstract WP109: Glucagon-Like Peptide-1 Has Anti-Inflammatory Effects Through Increasing IB1, A Scaffold Regulator Of JNK, In Cerebral Ischemia
Background and Purpose:
Hyperglycemia is frequently observed in patients with acute ischemic stroke, and conversely, diabetic patients showed a high frequency of stroke...

